Correlation Between Cue Biopharma and Dyne Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Dyne Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Dyne Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and Dyne Therapeutics, you can compare the effects of market volatilities on Cue Biopharma and Dyne Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Dyne Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Dyne Therapeutics.
Diversification Opportunities for Cue Biopharma and Dyne Therapeutics
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Cue and Dyne is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Dyne Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dyne Therapeutics and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Dyne Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dyne Therapeutics has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Dyne Therapeutics go up and down completely randomly.
Pair Corralation between Cue Biopharma and Dyne Therapeutics
Considering the 90-day investment horizon Cue Biopharma is expected to under-perform the Dyne Therapeutics. In addition to that, Cue Biopharma is 1.76 times more volatile than Dyne Therapeutics. It trades about -0.18 of its total potential returns per unit of risk. Dyne Therapeutics is currently generating about -0.02 per unit of volatility. If you would invest 3,110 in Dyne Therapeutics on August 25, 2024 and sell it today you would lose (141.00) from holding Dyne Therapeutics or give up 4.53% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cue Biopharma vs. Dyne Therapeutics
Performance |
| Timeline |
| Cue Biopharma |
| Dyne Therapeutics |
Cue Biopharma and Dyne Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cue Biopharma and Dyne Therapeutics
The main advantage of trading using opposite Cue Biopharma and Dyne Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Dyne Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyne Therapeutics will offset losses from the drop in Dyne Therapeutics' long position.| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
| Dyne Therapeutics vs. Stoke Therapeutics | Dyne Therapeutics vs. Pliant Therapeutics | Dyne Therapeutics vs. Cytokinetics | Dyne Therapeutics vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |